investorscraft@gmail.com

Intrinsic ValuePZ Cussons Plc (PZC.L)

Previous Close£73.00
Intrinsic Value
Upside potential
Previous Close
£73.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

PZ Cussons Plc operates in the consumer defensive sector, specializing in household and personal products across Europe, the Americas, Asia Pacific, and Africa. The company’s diversified portfolio spans baby care, beauty, hygiene, and home appliances, marketed under well-known brands such as Cussons Baby, Carex, Imperial Leather, and Haier Thermocool. Its revenue model relies on manufacturing, distribution, and direct sales, leveraging a mix of mass-market and premium segments to cater to diverse consumer needs. PZ Cussons maintains a strong regional presence, particularly in Africa, where it holds a competitive edge through localized production and distribution networks. The company’s market positioning is reinforced by its heritage brands and innovation in product development, though it faces stiff competition from global giants like Unilever and Procter & Gamble. Strategic focus on high-growth categories, such as baby nutrition and beauty, supports its resilience in volatile markets.

Revenue Profitability And Efficiency

PZ Cussons reported revenue of 527.9 million GBp for FY 2024, reflecting its broad product reach. However, net income stood at a loss of 57 million GBp, with diluted EPS at -0.14 GBp, indicating profitability challenges. Operating cash flow was positive at 12.9 million GBp, though capital expenditures of 6.1 million GBp suggest restrained investment activity. The company’s efficiency metrics highlight margin pressures amid rising costs.

Earnings Power And Capital Efficiency

The negative net income and EPS underscore earnings weakness, likely driven by inflationary pressures and competitive dynamics. Operating cash flow, though positive, is insufficient to offset profitability declines. Capital efficiency appears constrained, with limited reinvestment into growth initiatives. The company’s ability to improve returns hinges on cost optimization and portfolio rationalization.

Balance Sheet And Financial Health

PZ Cussons holds 51.3 million GBp in cash and equivalents against total debt of 178.7 million GBp, indicating moderate leverage. The balance sheet remains manageable, but the net loss raises concerns about sustained financial flexibility. Liquidity is adequate, though debt servicing could strain cash reserves if profitability does not recover.

Growth Trends And Dividend Policy

Revenue trends suggest stagnant growth, with profitability headwinds overshadowing top-line stability. The company maintains a dividend payout of 4 GBp per share, signaling commitment to shareholders despite earnings challenges. Future growth may depend on strategic divestitures or category-focused expansions in emerging markets.

Valuation And Market Expectations

With a market cap of approximately 357 million GBp and a beta of 0.40, PZ Cussons is viewed as a low-volatility defensive play. However, negative earnings and muted growth prospects likely weigh on valuation multiples. Investors may be pricing in a turnaround or asset monetization potential.

Strategic Advantages And Outlook

PZ Cussons benefits from brand equity and regional diversification, but operational inefficiencies and competitive pressures pose risks. The outlook remains cautious, with success contingent on cost management and targeted innovation. Strategic shifts toward higher-margin segments could revive long-term prospects.

Sources

Company filings, London Stock Exchange data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount